These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24582516)

  • 1. Targeted therapies in metastatic esophageal cancer: advances over the past decade.
    Mohamed A; El-Rayes B; Khuri FR; Saba NF
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):186-96. PubMed ID: 24582516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target Therapy for Esophageal Adenocarcinoma.
    Lam KO; Kwong DLW
    Methods Mol Biol; 2018; 1756():51-65. PubMed ID: 29600359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in esophageal cancer.
    Zhang L; Ma J; Han Y; Liu J; Zhou W; Hong L; Fan D
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):595-604. PubMed ID: 26895097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
    Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecularly targeted therapies in advanced gastric cancer.
    Janjigian YY; Shah MA
    Minerva Gastroenterol Dietol; 2011 Mar; 57(1):75-88. PubMed ID: 21372772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey.
    Aprile G; Giampieri R; Bonotto M; Bittoni A; Ongaro E; Cardellino GG; Graziano F; Giuliani F; Fasola G; Cascinu S; Scartozzi M
    Expert Opin Investig Drugs; 2014 Jul; 23(7):925-42. PubMed ID: 24806575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions.
    Young K; Chau I
    Drugs; 2016 Jan; 76(1):13-26. PubMed ID: 26620367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor: an important target in esophageal cancer.
    Hong L; Han Y; Brain L
    Expert Opin Ther Targets; 2013 Oct; 17(10):1179-85. PubMed ID: 23855932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced or metastatic pancreatic cancer: molecular targeted therapies.
    Bayraktar S; Rocha-Lima CM
    Mt Sinai J Med; 2010; 77(6):606-19. PubMed ID: 21105124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted agents and esophageal cancer--the next step?
    Aklilu M; Ilson DH
    Semin Radiat Oncol; 2007 Jan; 17(1):62-9. PubMed ID: 17185199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in gastric cancer.
    Thiel A; Ristimäki A
    APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology.
    Howard SA; Rosenthal MH; Jagannathan JP; Krajewski KM; Shinagare AB; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2015 May; 204(5):919-32. PubMed ID: 25905926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants in targeted therapy for esophageal adenocarcinoma.
    Vallböhmer D; Peters JH; Kuramochi H; Oh D; Yang D; Shimizu D; DeMeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; Danenberg PV; DeMeester TR
    Arch Surg; 2006 May; 141(5):476-81; discussion 481-2. PubMed ID: 16702519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer.
    Ayyappan S; Prabhakar D; Sharma N
    Anticancer Res; 2013 Oct; 33(10):4139-55. PubMed ID: 24122977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Gastroesophageal Adenocarcinoma Targeted Therapies.
    Maron SB; Catenacci DVT
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):511-527. PubMed ID: 28501091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.
    Burtness B; Bauman JE; Galloway T
    Lancet Oncol; 2013 Jul; 14(8):e302-9. PubMed ID: 23816296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophagogastric cancer: targeted agents.
    Ku GY; Ilson DH
    Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies for esophageal cancer.
    Tew WP; Kelsen DP; Ilson DH
    Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.